X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21316) 21316
Book Review (2712) 2712
Publication (1009) 1009
Newsletter (812) 812
Conference Proceeding (54) 54
Book Chapter (40) 40
Newspaper Article (10) 10
Dissertation (8) 8
Government Document (8) 8
Magazine Article (4) 4
Report (4) 4
Web Resource (3) 3
Reference (2) 2
Book / eBook (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18410) 18410
humans (14732) 14732
female (11859) 11859
cyclophosphamide (11640) 11640
male (8891) 8891
oncology (8205) 8205
middle aged (7888) 7888
adult (7428) 7428
cyclophosphamide - administration & dosage (6679) 6679
antineoplastic combined chemotherapy protocols - therapeutic use (6323) 6323
chemotherapy (5727) 5727
aged (5696) 5696
animals (4743) 4743
cancer (4237) 4237
treatment outcome (3904) 3904
hematology (3819) 3819
cyclophosphamide - therapeutic use (3236) 3236
antineoplastic combined chemotherapy protocols - adverse effects (3229) 3229
mice (2838) 2838
cyclophosphamide - adverse effects (2803) 2803
doxorubicin - administration & dosage (2791) 2791
therapy (2780) 2780
adolescent (2642) 2642
care and treatment (2483) 2483
breast neoplasms - drug therapy (2336) 2336
transplantation (2325) 2325
antineoplastic combined chemotherapy protocols - administration & dosage (2269) 2269
cyclophosphamide - toxicity (2178) 2178
vincristine - administration & dosage (2115) 2115
research (1914) 1914
breast cancer (1878) 1878
toxicity (1871) 1871
disease-free survival (1860) 1860
combined modality therapy (1821) 1821
drug administration schedule (1813) 1813
retrospective studies (1796) 1796
doxorubicin (1766) 1766
dose-response relationship, drug (1701) 1701
prognosis (1701) 1701
child (1700) 1700
immunology (1688) 1688
abridged index medicus (1671) 1671
survival analysis (1609) 1609
pharmacology & pharmacy (1578) 1578
rats (1557) 1557
rituximab (1521) 1521
survival rate (1505) 1505
medicine & public health (1472) 1472
follow-up studies (1471) 1471
etoposide - administration & dosage (1435) 1435
analysis (1431) 1431
neoplasm staging (1414) 1414
survival (1387) 1387
time factors (1381) 1381
aged, 80 and over (1351) 1351
health aspects (1312) 1312
trial (1309) 1309
prednisone - administration & dosage (1308) 1308
remission induction (1249) 1249
cisplatin - administration & dosage (1235) 1235
drug therapy, combination (1228) 1228
child, preschool (1196) 1196
antineoplastic agents - therapeutic use (1160) 1160
cisplatin (1144) 1144
methotrexate - administration & dosage (1131) 1131
breast neoplasms - pathology (1128) 1128
risk factors (1097) 1097
cyclophosphamide - pharmacology (1093) 1093
anthracyclines (1082) 1082
stem cells (1055) 1055
prospective studies (1047) 1047
drug therapy (1046) 1046
fluorouracil - administration & dosage (1029) 1029
immunosuppressive agents - therapeutic use (1026) 1026
etoposide (1019) 1019
young adult (1012) 1012
doxorubicin - adverse effects (1007) 1007
paclitaxel (1005) 1005
toxicology (964) 964
non-hodgkins-lymphoma (959) 959
lymphomas (957) 957
hematology, oncology and palliative medicine (954) 954
methotrexate (945) 945
doxorubicin - therapeutic use (938) 938
bone-marrow-transplantation (932) 932
carcinoma (919) 919
recurrence (910) 910
antineoplastic agents (892) 892
leukemia (877) 877
clinical trials (864) 864
vincristine (864) 864
vincristine - therapeutic use (862) 862
hematopoietic stem cell transplantation (861) 861
ovarian neoplasms - drug therapy (848) 848
antineoplastic agents - administration & dosage (843) 843
children (814) 814
clinical trials as topic (808) 808
chemotherapy, adjuvant (804) 804
bone marrow transplantation (799) 799
dosage and administration (797) 797
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21413) 21413
Russian (151) 151
Japanese (143) 143
German (127) 127
French (107) 107
Chinese (90) 90
Spanish (59) 59
Italian (27) 27
Polish (21) 21
Portuguese (16) 16
Korean (11) 11
Czech (7) 7
Persian (4) 4
Dutch (3) 3
Hungarian (3) 3
Serbian (3) 3
Turkish (3) 3
Ukrainian (3) 3
Bulgarian (2) 2
Danish (2) 2
Romanian (2) 2
Hebrew (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Applied Toxicology, ISSN 0260-437X, 02/2014, Volume 34, Issue 2, pp. 139 - 148
Journal Article
European Journal of Haematology, ISSN 0902-4441, 07/2016, Volume 97, Issue 1, pp. 25 - 32
Journal Article
Journal Article
Journal of Nutrition, ISSN 0022-3166, 2015, Volume 145, Issue 7, pp. 1472 - 1480
Journal Article
The Lancet, ISSN 0140-6736, 2002, Volume 360, Issue 9332, pp. 505 - 515
Journal Article
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 04/2013, Volume 65, Issue 4, pp. 604 - 614
Objectives This study investigated the protective efficacy of crocin against hepatotoxicity induced by cyclophosphamide (CP) in Wistar rats. Methods The... 
cyclophosphamide | crocin | inflammation | hepatotoxicity | oxidative stress | APOPTOSIS | ACROLEIN | PICTURE | SAFFRON | ALPHA-LIPOIC ACID | INDUCED LIVER-INJURY | DAMAGE | METABOLISM | INDUCED OXIDATIVE STRESS | PHARMACOLOGY & PHARMACY | ANTICANCER DRUGS | Liver - pathology | Reactive Oxygen Species - metabolism | Rats, Wistar | Protein Carbonylation - drug effects | Cyclophosphamide - adverse effects | Liver - immunology | Liver - drug effects | Protein Processing, Post-Translational - drug effects | Carotenoids - therapeutic use | Lipid Peroxidation - drug effects | Cyclophosphamide - antagonists & inhibitors | Chemical and Drug Induced Liver Injury - pathology | Cytokines - blood | Biomarkers - metabolism | Chemical and Drug Induced Liver Injury - prevention & control | Food Coloring Agents - therapeutic use | Antineoplastic Agents, Alkylating - antagonists & inhibitors | Oxidoreductases - metabolism | Liver - metabolism | Rats | Biomarkers - blood | Chemical and Drug Induced Liver Injury - immunology | Hydrogen Peroxide - metabolism | Antioxidants - therapeutic use | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Chemical and Drug Induced Liver Injury - metabolism | Oxidative Stress - drug effects | Antineoplastic Agents, Alkylating - adverse effects | Antioxidants | Antimitotic agents | Cyclophosphamide | Coloring matter | Liver diseases | Cytokines | Glutathione transferase | Aspartate | Superoxide | Antineoplastic agents | Enzymes | Toxicity | Rodents | Index Medicus
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 11/2017, Volume 66, Issue 11, pp. 1425 - 1436
The primary aim of this clinical trial was to determine the feasibility of delivering first-generation CAR T cell therapy to patients with advanced, CEACAM5+... 
Persistence | Immunology | Medicine & Public Health | Chimeric antigen receptor | Toxicity | Oncology | Cancer Research | T cells | CEA | TARGET | CHIMERIC IMMUNE RECEPTORS | METASTASES | IMMUNOLOGY | CANCER | TRIAL | ONCOLOGY | IMMUNOTHERAPY | LYMPHOMA | GENE-THERAPY | PHASE-I | LYMPHOCYTES | Cyclophosphamide - administration & dosage | Myeloablative Agonists - adverse effects | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Carcinoembryonic Antigen - genetics | Drug Resistance, Neoplasm | Male | Interferon-gamma - metabolism | Myeloablative Agonists - agonists | Cyclophosphamide - adverse effects | T-Lymphocytes - transplantation | Carcinoembryonic Antigen - metabolism | Neoplasms - therapy | Neoplasms - genetics | T-Lymphocytes - metabolism | Adult | Female | Receptors, Antigen, T-Cell - immunology | Lung - metabolism | Interleukin-6 - metabolism | Anemia - etiology | Immunotherapy, Adoptive - adverse effects | Immunotherapy, Adoptive - methods | Abdominal Pain - etiology | GPI-Linked Proteins - immunology | Receptors, Antigen, T-Cell - metabolism | Carcinoembryonic Antigen - immunology | Vidarabine - adverse effects | Treatment Outcome | Vidarabine - analogs & derivatives | GPI-Linked Proteins - metabolism | Neoplasms - immunology | Interferon-gamma - immunology | Interleukin-6 - immunology | Vomiting - etiology | T-Lymphocytes - immunology | Aged | Receptors, Antigen, T-Cell - genetics | Vidarabine - administration & dosage | Cohort Studies | GPI-Linked Proteins - genetics | CEA (Oncology) | Cells | Cytokines | Control methods | Lung | Feasibility studies | Lymphocytes T | Malignancy | Epithelium | Patients | Interleukin 6 | Infusion | Carcinoembryonic antigen | Cyclophosphamide | Elevated | Cell activation | Fludarabine | Interleukin 2 | Lymphocytes | Production methods | γ-Interferon | Biocompatibility | Preconditioning | Index Medicus | Original
Journal Article